Jose-Carlos Gutiérrez-Ramos
Chief Tech/Sci/R&D Officer at DANAHER CORPORATION
Net worth: 4 M $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Aoife Brennan | M | 48 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 years |
Matthew McGrew | M | 52 | - | |
Richard Shea | M | 72 | 21 years | |
Steven Rales | M | 72 | 41 years | |
Nick Leschly | M | 51 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 years |
Noubar Afeyan | M | 60 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | 6 years |
Rainer Blair | M | 60 | 14 years | |
Kevin Lee | M | 55 | 12 years | |
Santiago Arroyo | M | 64 | 7 years | |
Mitchell Rales | M | 67 | 41 years | |
Alistair Milnes | M | 50 | 3 years | |
Michael Powell | M | 69 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 7 years |
Michael Skynner | M | 55 | 11 years | |
Jessica Mega | M | 49 | 5 years | |
Michael Thomas Ropacki | M | - | 5 years | |
Thomas J. Adam | M | - | 7 years | |
Christopher Bouda | M | 47 | 8 years | |
Stephen Sands | M | 67 | - | |
A. Sanders | M | 61 | 3 years | |
Brian Ellis | M | 58 | 8 years | |
Raymond Stevens | M | 60 | 7 years | |
Travis Thompson | M | - | 6 years | |
Alan Spoon | M | 72 | 25 years | |
Teri List-Stoll | F | 61 | 13 years | |
Gregory Winter | M | 73 | 15 years | |
Peter Barrett | M | 71 | 7 years | |
Walter Lohr | M | 80 | 41 years | |
Helen Hobbs | M | 71 | 13 years | |
Linda Filler | F | 64 | 20 years | |
Jim Smith | M | 64 | 10 years | |
Janice Bourque | F | 67 | 5 years | |
Richard Kender | M | 68 | 5 years | |
Shantanu Narayen | M | 60 | 11 years | |
Elias Zerhouni | M | 72 | 15 years | |
John Schwieters | M | 84 | 21 years | |
Feroz Dewan | M | 47 | 2 years | |
Thomas Freyman | M | 69 | 4 years | |
Caroline Kurtz | M | - | 8 years | |
Steve Danehy | M | - | 12 years | |
Nigel Crockett | M | 59 | 5 years | |
Georgeann Couchara | F | 48 | 20 years | |
Joakim Weidemanis | M | 55 | 13 years | |
Duane van Arsdale | M | - | 4 years | |
Daniel Raskas | M | 57 | 20 years | |
Travis Taylor | M | - | 3 years | |
A. JOSEPH ALEX | M | - | - | |
Jonathan Bryant | M | - | 4 years | |
Agnieszka Cieplinska | F | - | 5 years | |
Susan Hohenleitner | F | - | 4 years | |
Carrie Strom | F | - | 4 years | |
Zafar Qadir | M | - | 4 years | |
John Bedford | M | - | 3 years | |
Alex de Winter | M | - | 4 years | |
Nicholas Keen | M | 56 | 7 years | |
Pardis Sabeti | M | 48 | 5 years | |
Sadik Kassim | M | - | 3 years | |
Pierre Legault | M | 63 | 5 years | |
William King | M | 56 | 26 years | |
James F. O'Reilly | M | - | - | |
Elizabeth Gordon | M | - |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | - |
Jennifer Perry | F | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeffrey Kindler | M | 68 | 8 years | |
William Steere | M | 87 | 28 years | |
Simba Gill | M | 60 | 8 years | |
Craig Wheeler | M | 63 | 14 years | |
Michelle Robertson | F | 57 | 3 years | |
Ankit Mahadevia | M | 43 | 3 years | |
Lord Darzi | M | 63 | 5 years | |
Alison D. Silva | F | 46 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 3 years |
Todd Shegog | M | 59 | 3 years | |
Lee Kalowski | M | 43 | 6 years | |
Ann Thorell | F | 56 | 1 years | |
Alejandra Carvajal | F | 50 | 4 years | |
Ganesh Venkataraman Kaundinya | M | 57 | 17 years | |
Louis J. Arcudi | M | 63 |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | 7 years |
David Epstein | M | 62 | 6 years | |
Bruce Downey | M | 76 | 11 years | |
Amy Schulman | F | 63 | 6 years | |
Yi Ning Zhao | M | 53 | 8 years | |
John Hohneker | M | 64 | 2 years | |
Maiken Keson-Brookes | F | 52 | - | |
Everett Cunningham | M | 57 | 9 years | |
Scott M. Storer | M | - | 2 years | |
Tonya Williams | F | 50 | 1 years | |
Georges Gemayel | M | 64 | 4 years | |
Robert Landry | M | 60 | 4 years | |
Marc Tessier-Lavigne | M | 64 | 4 years | |
Elizabeth Stoner | M | 73 | 13 years | |
Patricia Ann Walicke | M | 71 |
Avidia, Inc.
Avidia, Inc. Pharmaceuticals: MajorHealth Technology Avidia, Inc. developed pharmaceutical products. The company developed a novel, proprietary class of small therapeutic proteins. The company was headquartered in Mountain View, CA. | 1 years |
Bharatt Chowrira | M | 59 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 2 years |
Donna Grogan | M | 67 | 1 years | |
Corey N. Fishman | M | 59 | 4 years | |
Thomas Paul Koestler | M | 71 | 9 years | |
Ronald O. Robison | M | - | - | |
Steven Gilman | M | 71 | 4 years | |
Bruce A. Leicher | M | 68 | 10 years | |
James Sulat | M | 73 | 11 years | |
Robert N. Burt | M | 86 | 11 years | |
Marsha Fanucci | F | 70 | 11 years | |
Scott Cundy | M | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 87 | 87.00% |
United Kingdom | 15 | 15.00% |
Spain | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jose-Carlos Gutiérrez-Ramos
- Personal Network